The popular weight-loss drug Wegovy has been available in Canada since early May, but anybody hoping to use it will have to shell out about $400 a month. One advocate says that lack of coverage will ...

Wegovy is a brand-name injection prescribed for weight management and to lower risk of cardiovascular problems. Wegovy contains the active ingredient semaglutide and belongs to the GLP-1 drug class.

Health Canada has approved Novo Nordisk's weight-loss drug Wegovy to reduce the risk of non-fatal heart attack, the drug maker says. Novo Nordisk said Wednesday that Wegovy is the first Health ...

Reviews and recommendations are unbiased and products are independently selected. Postmedia may earn an affiliate commission from purchases made through links on this page. Patients who took an ...

Headaches are a possible side effect of Wegovy. Although these headaches are often mild and short term, they may interfere with your daily activities. Here’s what to know about headaches during Wegovy ...

Stopping Wegovy, especially suddenly, can lead to weight regain, potentially reversing progress made during treatment. Ending Wegovy treatment may also increase cardiovascular risks and raise blood ...

Imagine this scenario: You’ve been diligently working toward your weight management goals, and your healthcare team has prescribed Wegovy (semaglutide). You’re excited, you’ve done your research, and ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. The short-term effects of Wegovy include appetite control and weight loss. But if you’re considering taking it for the long haul (or ...

Bagsværd, Denmark, 15 August 2025 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved an additional indication for Wegovy ® (semaglutide 2.4 mg) based on a ...

Why Am I Not Losing Weight on Wegovy®? How to Get Results Key takeaways: Not losing weight on Wegovy® could be due to dose, ...

India has taken a big step forward in obesity treatment with the launch of the much-talked-about weight-loss drug Wegovy by Danish drugmaker Novo Nordisk. After getting approval from the US Food and ...